← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Martin Jönsson
Styrelseledamot | Verkställande direktör (VD)
Profile key: se|martin jönsson
Purchase history
- Companies traded
- 5
- Purchases · 12M
- 10
- Purchases · 24M
- 15
- Average purchase
- SEK 761,750
- Gross purchase value
- SEK 11,426,252
- Last purchase
- 2026-07-20
- Completed 20D events
- 10.0
- Outcome status
- PASS
Latest company: Sonetel AB (publ)
Companies: AlzeCure Pharma AB | Briox | Briox AB | Nordnet AB (publ) | Sonetel AB (publ)
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 10Developing | 100.0% (10/10) | 40.0% (4/10) | -2.3% | +0.6% | -7.1% |
| 20D | 10Developing | 100.0% (10/10) | 40.0% (4/10) | -5.9% | -3.5% | -25.6% |
| 60D | 10Developing | 100.0% (10/10) | 30.0% (3/10) | -7.5% | -11.4% | -44.0% |
| 120D | 7Developing | 100.0% (7/7) | 14.3% (1/7) | -29.8% | -13.0% | -67.4% |
Research patterns
- First purchase in 12M
- 3/8
- Large purchase ≥ €100k
- 2/10
- Cluster buying · 15D
- 5/10
- Buying the dip · ≥20% below prior 52W high
- 5/10
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.